Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor

By Kusama Toshiyuki   Mukai Mutsuko   Tatsuta Masaharu   Matsumoto Yoshirou   Nakamura Hiroyuki   Inoue Masahiro  

Clinical and Experimental Metastasis, Vol. 20, Iss. 6, 2003-10 ,pp. : 561-567

Springer Publishing Company

Access to resources Recommend Favorite

The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 804-812

Spandidos Publications

Access to resources Recommend Favorite

The Use of Molecular Markers in Farnesyltransferase Inhibitor (FTI) Therapy of Breast Cancer

By Moasser M.M.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite

Adoptively transferred ex vivo expanded -T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer

By Beck Benjamin  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite